Supplementary Figure S1 from Telisotuzumab Adizutecan (ABBV-400), a Novel c-Met–Targeting Antibody–Drug Conjugate: First-in-Human Results in Advanced Gastric/Gastroesophageal Junction Cancer

作者：John H. Strickler, Judith Raimbourg, Jonathan Cohen, François Ghiringhelli, Manish R. Sharma, Chiyoe Kitagawa, Ki Hyeong Lee, Bert H. O’Neil, Maria J. de Miguel, Esma Saada-Bouzid, Rui Li, Nandini Rudra-Ganguly, Adam Luo, Apurvasena Parikh, Gladys Morrison, Martha Neagu Aristide, Zoë Hunter, Michael C. Burns, Yasutoshi Kuboki · 年份：2026 · DOI：10.1158/1078-0432.33158538 · 研究领域：Medicine、Cancer research、Internal medicine、Radiology、Oncology

<p>Supplementary Figure S1. Study design.</p>